AI biotech Iambic debuts next-gen model Enchant for drug R&D
Iambic Therapeutics claims that it has improved the predictive power of its AI model Enchant by scaling it up, in what one of the company’s co-founders says is a “material shift” for its drug discovery ...
Iambic Therapeutics claims that it has improved the predictive power of its AI model Enchant by scaling it up, in what one of the company’s co-founders says is a “material shift” for its drug discovery ...
